YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Toward the end of the October 1 lightning round of Mad Money, a caller asked about Kimberly-Clark Corporation (NASDAQ:KMB) and its pending acquisition of Kenvue Inc. (NYSE:KVUE). They highlighted Kimberly-Clark's difficult stock performanc…
Kimberly-Clark (KMB) is reshaping its future leadership as it prepares to close the pending Kenvue acquisition. Several senior executives are set to depart, and Kenvue leaders will step into key regional roles. Recent trading has been toug…
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Newell Brands (NWL) or Kenvue (KVUE). But which of these two stocks is more attractive to value investors? We'll need to take a closer loo…
Kimberly-Clark's planned acquisition of Kenvue (KVUE) just came with a detailed leadership reshuffle, including new regional heads and integration leads, putting the consumer health group's future governance firmly in focus for shareholder…
The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off. Continue Reading
Kenvue has delivered a 16.1% gain over the past year, even as shorter term returns have been softer. This puts fresh focus on whether the current share price lines up with the cash the business can generate over time. With the stock last c…
Russ Torres to Depart Kimberly-Clark for External CEO Role Carlos De Jesus to be Appointed as President, North America and Leonardo Curado to be Appointed as President, EMEA After Kenvue Acquisition DALLAS, Oct. 1, 2026 /PRNewswire/ -- Kim…
Global research shows oral disease case numbers rose more than 3% over four years, as researchers warn that progress is too slow to meet the WHO's 2030 target. This World Smile Day, LISTERINE® is launching Oral Care Counts – a multiyear ed…
Kimberly-Clark has had a rough stretch in the market over the past year, and that weak share performance puts fresh focus on one core issue: whether the current price around US$97 is sensible when you line it up against the cash the busine…
Kimberly-Clark (NasdaqGS:KMB) has launched exchange offers and consent solicitations for Kenvue's outstanding notes tied to its pending acquisition. The proposal gives Kenvue bondholders the option to swap existing securities into new Kimb…
Research shared at the 35th European Academy of Dermatology and Venereology (EADV) Congress highlights the benefits of multifunctional sunscreens, colloidal oat formulations addressing acne, hyperpigmentation, eczema, UV-related skin damag…
DALLAS, Sept. 28, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the commencement, in connection with its previously announced pending acquisition ("Acquisition") of Kenvue Inc. (NYSE: KVUE…
Quick Read Five beaten-down Dividend Kings offer strong upside heading into 2027, including Hormel (5.4% yield) and PepsiCo (4.2% yield). Kimberly-Clark fell 23% in 2025 to near a 12-year low yet has raised its dividend for 53 straight yea…
Wall Street goes through cycles in which companies buy assets to create diversified conglomerates, and then sell assets to streamline and focus. Right now, investors are rewarding companies for simplifying their operations and focusing the…
This article first appeared on GuruFocus. A Deep Dive Into the Consumer Health Giant's Upcoming Payout, Yield, and Long-Term Dividend Sustainability Kenvue Inc (NYSE:KVUE) recently announced a total dividend of $0.21 per share, with the ex…
Kimberly-Clark (NasdaqGS:KMB) plans to sell assets tied to its planned US$40b acquisition of consumer products group Kenvue. The disposals are aimed at addressing European Union antitrust concerns linked to overlaps in consumer health and…
Dividend investors looking for a defensive healthcare candidate will likely come across companies like Johnson & Johnson (NYSE: JNJ) and Kenvue (NYSE: KVUE), and the next natural question is which one deserves a permanent spot in a dividen…
Kenvue Inc. previously announced that its Board of Directors declared a quarterly dividend of US$0.21 per share, payable on October 2, 2026, to shareholders of record as of September 21, 2026, while also securing FDA approval for TYLENOL w…
Kenvue (KVUE) is on investors' radar after launching TYLENOL with Naproxen, an FDA-approved, opioid-free over the counter pain reliever that combines acetaminophen and naproxen sodium, backed by extensive clinical research. That launch com…
Kimberly-Clark Corporation (NASDAQ:KMB) is preparing asset sales to address EU antitrust concerns surrounding its planned $40 billion acquisition of Kenvue, according to Reuters. The company is reportedly seeking to offer remedies that cou…
Consumer stocks were mixed late Monday afternoon, with the State Street Consumer Staples Select Sect PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Kenvue (NYSE: KVUE) is often overlooked when investors think about the best healthcare dividend stocks. The company was only spun off from Johnson & Johnson three years ago, but counting its time as the consumer healthcare division with th…
Quick Read Colgate-Palmolive (CL) hired Goldman Sachs to explore selling Softsoap, Irish Spring, and Speed Stick as North America revenue fell 3% in Q2 2026. Private equity leads as the likeliest buyer, with every named strategic acquirer…
MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ -- Sorbent Paper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Ze…
Businessman trading stock market on teblet screen by Nespix via iStock Summit, New Jersey-based Kenvue Inc. (KVUE) is a global consumer health company offering everyday health and wellness products through iconic brands. Its portfolio help…
Quick Read KMB extended its 54-year dividend increase streak to $5.12 annualized while closing a $48.7 billion KVUE acquisition that pressures an already thin balance sheet. Operating cash flow of $2.8 billion barely covers $1.66 billion i…
Kimberly Clark (NASDAQ: KMB) has increased its dividend annually for over five decades, making it a Dividend King. That's a huge achievement. It also offers an attractive 5% dividend yield, with its stock price having fallen more than 20%…
* Kenvue (KVUE [https://seekingalpha.com/symbol/KVUE]) declares $0.21/share quarterly dividend [https://seekingalpha.com/pr/20646345-kenvue-declares-quarterly-cash-dividend], in line with previous. * Forward yield [https://seekingalpha.com…
SUMMIT, N.J., September 10, 2026--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock. The quarterly dividend is payable on October 2, 2…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…
Kenvue Inc. KVUE holds a strong position in the consumer health market, backed by a portfolio of trusted brands, extensive global presence and continued investments in innovation. The company's portfolio features well-established names, in…
Kimberly-Clark Corporation's (NASDAQ:KMB) proposed $40 billion takeover of Kenvue has entered another stage of regulatory review. Documents on the European Commission's website show that Kimberly-Clark has requested EU permission to comple…
Kenvue Inc. KVUE is moving closer to its planned combination with Kimberly-Clark Corporation KMB, with shareholder approvals secured and the U.S. antitrust waiting period expired. The cash-and-stock transaction is expected to close in the…
Kenvue Inc. KVUE is showing better earnings leverage than its sales growth alone would suggest. In the first half of 2026, adjusted operating margin rose 180 basis points to 23.1% and adjusted earnings increased 18.9% to 63 cents per share…
With 55 years of consecutive dividend growth, Kimberly-Clark (NASDAQ: KMB) is one of the Dividend Kings. Despite this distinction, bearish sentiment persists for this consumer staples stock. Why? Blame it on its pending acquisition of Kenv…
Kimberly-Clark (KMB) stock is in focus after the company named Suzana Blades as Senior Vice President and General Counsel, with a future role tied to its pending acquisition of Kenvue Inc. Kimberly-Clark shares trade at US$110.34, with the…